Pantoprazole

CAS 102625-70-7 28 API suppliersSmall Molecule

Overview

Pantoprazole is a proton pump inhibitor that decreases the amount of acid produced in the stomach and is used to treat erosive esophagitis and other conditions involving excess stomach acid, such as Zollinger-Ellison syndrome. It is available as a generic medication and under various trade names worldwide.

API suppliers (28)

Suppliers of Pantoprazole evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India21USA1United Kingdom1

Country recorded for 23 of 28 suppliers.

15 of 28 hold a GMP certificate on record in the EU or UK registers

Showing 25 of 28 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (51 approved US products), the latest listed US patent on Pantoprazole expires 7 Dec 2026 and exclusivity 12 Aug 2027. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name
6-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridinyl)methylsulfinyl]-1H-benzimidazole
Canonical SMILES
COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
InChIKey
IQPSEEYGBUAQFF-UHFFFAOYSA-N

Therapeutic areas

GastroenterologyPharmacology
Verified Supplier Partner

Do you supply Pantoprazole? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.